Screened once, if at all
WHO recommends eight antenatal contacts. Most programmes can fund a hemoglobin test at one or two of them, so iron deficiency that develops in the second and third trimester goes unseen.
Nivamed estimates hemoglobin from one phone photo of the inner eyelid โ so anemia gets checked at every antenatal contact, not only the visits that reach a laboratory. No needle, no tube, no return trip.
Free during pilot ยท No card ยท Unsubscribe anytime
Hemoglobin usually gets measured at booking, then rarely again. Anemia develops across trimesters โ a single early reading says little about how a pregnancy is actually going.
WHO recommends eight antenatal contacts. Most programmes can fund a hemoglobin test at one or two of them, so iron deficiency that develops in the second and third trimester goes unseen.
Venipuncture needs a phlebotomist, transport and a return visit. In rural antenatal care that loop runs longer than the clinical window it was meant to inform.
Anemia at delivery is associated with preterm birth, low birth weight and greater vulnerability to postpartum hemorrhage. Iron treatment works โ but it needs weeks, not days.
No dongle, no cuff, no strip. The phone in the midwife's pocket is the instrument.
On-screen guides frame the palpebral conjunctiva โ the inner eyelid โ while the patient is being weighed or having blood pressure taken. Nivamed rejects the frame if focus, glare or exposure fall out of tolerance.
A convolutional backbone fine-tuned on patient-stratified folds maps tissue chromaticity to a hemoglobin value in g/L, cross-checked against a CIELAB feature model that flags disagreement.
You get a point estimate, a confidence interval and a triage band against the WHO pregnancy threshold of 110 g/L โ screen negative, borderline, or refer for CBC. Readings build a trend across the pregnancy.
A number is not a product. Nivamed ships the workflow that makes the number useful to a midwife.
The anemia cut-off moves through pregnancy. Nivamed bands each reading against the threshold for that gestational age instead of one flat number.
Ambient light, white balance and device profile are captured with every frame. Out-of-envelope shots are rejected, not silently guessed.
Caseload by gestational week, referral queue, and who has missed a screening. See a patient's whole pregnancy on one trend line.
Age, trimester, fatigue, pica, dizziness and shortness of breath feed a companion model, so you always see what the image adds over the questions a midwife already asks.
Inference runs on-device. Screenings queue locally and sync when a signal appears โ designed for home visits, not hospitals.
Identifiers hashed at capture. Images never leave the device unless a clinician opts in. No laboratory value ever reaches the model at inference.
Anemia screening from images has a long history of overstated accuracy. Nivamed reports against the honest baseline: what you would get by ignoring the image and guessing the cohort mean.
Reported on a development cohort of 130 pregnant patients at a single site, using the WHO pregnancy threshold of 110 g/L. This is proof-of-concept performance, not deployment evidence โ multi-site and multi-device validation is in progress, and severe anemia is too rare in this cohort to model separately.
Fatigue, breathlessness and dizziness are normal in pregnancy until they are not. Check between appointments and bring a trend to your midwife instead of a feeling.
Screen at intake while vitals are taken. Send only the borderline and low bands to venipuncture, and cut CBC volume without losing cases.
Equip community midwives and health workers with the phones they already own. Map anemia prevalence by district and route iron supplementation where it changes outcomes.
Image-based anemia screening has a long record of impressive numbers that fail to replicate. These are the rules we hold ourselves to.
Every accuracy figure is published next to what you would get by ignoring the image and guessing the cohort mean. A model that does not beat that number is not reported as working.
Cross-validation splits by patient, never by image. Splitting by image inflates results by letting the model memorise a face โ the single most common flaw in this literature.
An AUC above 0.95 on a cohort this size means something leaked, not that the model is excellent. We chase those down before publishing, not after someone else finds them.
Pilot partners keep pilot pricing for twelve months after general availability.
For anyone tracking their own pregnancy.
Priced per screening, with volume tiers.
Ministries, NGOs and multi-district programmes.
No. Nivamed is a screening and triage tool that sits alongside routine antenatal care. It indicates whether a laboratory test is warranted and how hemoglobin is trending. Diagnosis, iron therapy decisions and anything involving severe anemia require a CBC and a clinician.
Readings can be taken at any point in pregnancy. Hemoglobin falls naturally in the second trimester through plasma volume expansion, so the anemia threshold shifts with gestational age โ Nivamed bands each reading against the cut-off for that week rather than one flat number.
Nivamed takes an ordinary photograph. There is no needle, no radiation, no contact and no light source beyond the phone screen. The measurement itself carries no physical risk. The risk to manage is a missed case, which is why borderline readings are routed to a lab rather than cleared.
Primary regions are mucosal โ inner eyelid, tongue, lip โ where melanin contribution is minimal. Performance is reported stratified by Fitzpatrick group, and any region where a group underperforms is dropped from fusion for that group rather than averaged away.
Mixed lighting, coloured bulbs, heavy camera post-processing and flash reflections. The app checks white balance and exposure before accepting a frame and asks for a retake rather than returning a guess.
Inference is on-device. Images stay local unless a clinician explicitly opts into contributing them to validation, in which case identifiers are hashed at capture and no clinical laboratory values are attached.
Not yet. Nivamed is currently a research and wellness tool under active clinical validation. It is not a cleared medical device and must not be used as the sole basis for any decision in antenatal care.
Pilot slots open monthly. Bring an antenatal cohort, we bring the validation protocol.
Typical onboarding: 2 weeks from signed protocol to first screening.